About CARE™ / À propos de CARE™

The CARE™ Faculty is recognizing its 15th year in 20/20 and plans to continue its evolving discussion on biosimilars and access to innovation with robust programming in 20/20 and beyond.

The CARE™ (Community. Academic. Research. Education.) Faculty is a group of leading specialists and allied healthcare providers from across Canada.

We develop education initiatives directed at our peers, nurses, pharmacists, patients, government and private payers.

 

Le Comité académique de CARE™ (Community. Academic. Research. Education.) est un groupe d’éminents spécialistes et de fournisseurs de soins de santé connexes de partout au Canada.

Nous élaborons des initiatives de formation destinées à nos pairs, aux infirmières, aux pharmaciens, aux patients, au gouvernement ainsi qu’aux payeurs du secteur privé.

 

LEARN MORE / SAVOIR PLUS

Current Events / Évènements

[Recent] Publications

CARE™ at ASH happened on December 6th, 2019. It is the largest gathering of hematologists outside of Canada. CARE™ has provided a summary report and the speaker slides presentations.

View Publication

Hematology

CARE™ at ASH 2019:

Presentations & Report

Rheumatology

CARE™ Perspectives:

More Innovation Needed in Rheumatology

Select members of the CARE™ Rheumatology Faculty used the 2019 ACR conference as an opportunity to meet and discuss the impact of, and continued support for access to innovation and biosimilar adoption, specifically from a Canadian context/perspective.

View Publication

The CARE™ ACG/UEGW 2019 Conference Report highlights key news in gastroenterology with a specific focus on inflammatory bowel disease (IBD), framed from a Canadian perspective.

View Publication

Gastroenterology

 

 

CARE™ Perspectives:

ACG/UEGW 2019

Genitourinary

CARE™ Perspectives:

ESMO 2019

2018 and 2019 have seen numerous data updates and news that could affect the management of prostate cancer (PC) in Canada. The following CARE™ Conference Report from ESMO 2019 focuses on prostate cancer updates.

View Publication

Twitter

5 immunotherapy trials that made progress in lung cancer treatment. via Jack West and Charu Aggarwal.
http://ms.spr.ly/6012Tkh9A #lcsm

Infectious disease expert Allison Greer from @UofTMedicine on Wuhan coronavirus risks – & uncertainties #UofT 😷 https://uoft.me/58i

Load More...

Resources

Forum on Complement Case Series

This 4-part series sheds light on challenges many Paroxysmal Nocturnal Hemoglobinuria (PNH) patients encounter during their disease course.